הלוואות ואשראי לטווח ארוך של החברה: genfit.com (GNFT)

This chart illustrates that the market value of Genfit S.A. (GNFT) on the GURU.Markets platform is 0.00, which correlates with the commercial launch of Iqirvo and progress in liver failure therapy. The business relies on patent protection, allowing the company to generate massive profits with minimal drug production costs. The company's strategy is based on establishing R&D alliances with global leaders rather than pursuing mergers.

Long-term debt determines the financial stability of an issuer by measuring the total volume of obligations with a maturity exceeding one year. This metric assesses a company's ability to service loans without the risk of bankruptcy. By analyzing the long-term debt chart of a business, an investor can track the dynamics of the credit load. For Genfit S.A. (GNFT), such loans are critical for financing costly R&D research in hepatology until the commercialization of patents.